Gal, Jocelyn
180  results:
Search for persons X
?
1

Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate ..:

Chamorey, Emmanuel ; Pujalte-Martin, Marc ; Ferrero, Jean-Marc...
International Journal of Molecular Sciences.  25 (2024)  11 - p. 6058 , 2024
 
?
3

Enhanced liver fibrosis score is stable after withdrawal in..:

Lévi‐Strauss, Thomas ; Gal, Jocelyn ; Gelsi, Eve...
Alcohol, Clinical and Experimental Research.  48 (2024)  6 - p. 1088-1095 , 2024
 
?
8

Feasibility and early toxicity of intraoperative radiothera..:

Chand-Fouché, Marie-Eve ; Colnard, Claudine ; Gal, Jocelyn...
Clinical and Translational Radiation Oncology.  38 (2023)  - p. 47-52 , 2023
 
?
9

Survival analysis of patient groups defined by unsupervised..:

Bailleux, Caroline ; Chardin, David ; Guigonis, Jean-Marie...
Computational and Structural Biotechnology Journal.  21 (2023)  - p. 5136-5143 , 2023
 
?
11

10-Year oncological outcome report after second conservativ..:

Hannoun-Levi, Jean-Michel ; Gal, Jocelyn ; Schiappa, Renaud.
Clinical and Translational Radiation Oncology.  38 (2023)  - p. 71-76 , 2023
 
?
13

Application of machine learning methods to guide patient ma..:

D'Andréa, Grégoire ; Gal, Jocelyn ; Mandine, Loïc...
European Journal of Endocrinology.  188 (2023)  3 - p. 249-257 , 2023
 
?
14

Added value of [18F]FDOPA PET to the management of high-gra..:

Darcourt, Jacques ; Chardin, David ; Bourg, Véronique...
European Journal of Nuclear Medicine and Molecular Imaging.  50 (2023)  9 - p. 2727-2735 , 2023
 
?
15

Second Conservative Treatment for Local Recurrence Breast C..:

Hannoun-Levi, Jean-Michel ; Gal, Jocelyn ; Polgar, Csaba...
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  5 - p. 1200-1210 , 2023
 
1-15